Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07195916RecruitingPhase 1
Testing a new drug for advanced solid tumors and blood cancers
This trial tests a new drug called INCA036873, which targets CD70 on cancer cells, for people with advanced solid tumors or certain blood cancers that have not responded to prior treatments. The goal is to see if it is safe and effective against these tough-to-treat cancers.
Duarte, CaliforniaAges 18 years+ - NCT07197944RecruitingPhase 3
Glepaglutide for short bowel syndrome
This trial tests a new medication called glepaglutide to see if it can help people with short bowel syndrome (SBS) who need IV nutrition or fluids at least 3 days a week. The goal is to reduce or even stop the need for these IV treatments.
Chicago, IllinoisAges 18–90 - NCT07197814Recruiting
Tolerance of a rice protein formula in children with cow's milk allergy
This study tests a new formula made from rice protein in children who have a cow's milk allergy. It checks if the rice formula is well-tolerated without causing allergic reactions.
NaplesAges 1 month–3 years - NCT07195162Recruiting
Testing a digital tool for pain management
This trial is testing a digital workflow system to help doctors manage pain. It may be a good fit if you've had pain lasting at least a month.
HaifaAges 18–80 - NCT07203001RecruitingPhase 2
MAS825 for Still's disease in children and adults
This trial tests a new drug called MAS825 for people with Still's disease that is still active despite other treatments. It aims to see if the drug can reduce symptoms like fever, rash, joint pain, or a serious complication called macrophage activation syndrome.
Cincinnati, OhioAges 1 year+ - NCT07198139RecruitingPhase 1/Phase 2
Testing a new norovirus treatment in healthy adults
This trial tests an investigational medicine called CDI-988 to see if it can prevent or treat norovirus infection. Healthy adults will be intentionally exposed to a mild norovirus strain to see how the medicine works.
Decatur, GeorgiaAges 18–49 - NCT07195825RecruitingPhase 1
Gene therapy BBM-P002 for Parkinson's disease safety trial
This trial tests a new gene therapy called BBM-P002 for Parkinson's disease. It aims to see if the treatment is safe and tolerable, and may help people with moderate to advanced Parkinson's who have had the condition for at least 5 years.
Shanghai, Shanghai MunicipalityAges 40–70 - NCT07195656Recruiting
Electrical stimulation device for overactive bladder
This trial tests a non-surgical device that uses mild electrical stimulation to treat overactive bladder. It may help if you have a sudden, strong need to pee often or wake up at night to pee.
Beverly Hills, CaliforniaAges 21 years+ - NCT07200908RecruitingPhase 3
Comparing brelovitug and bulevirtide for hepatitis delta
This trial tests a new drug, brelovitug, against an existing one, bulevirtide, for people with chronic hepatitis delta. It aims to find a better treatment to lower the virus and protect the liver.
GrazAges 18–99 - NCT07195422Recruiting
Study of a new device for low back pain relief
This trial tests a wearable device called Japet.W+ to see if it can help reduce chronic low back pain. It might be an option for people who have had lower back pain for a long time and are looking for non-surgical relief.
Clermont-FerrandAges 18–80 - NCT07193459RecruitingPhase 3
Study of an oral tablet for type 2 diabetes
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
Beijing, Beijing MunicipalityAges 18–75 - NCT07202520Recruiting
Home virtual reality rehab for stroke recovery
This trial tests if using a virtual reality device at home after a stroke can help you regain independence. You'll use the device with a family member present for safety, after finishing your stay at a rehabilitation center.
BerckAges 18 years+ - NCT07193589RecruitingPhase 2
Testing ZL-82 tablets for moderate to severe eczema
This study tests if an oral tablet called ZL-82 can help people with moderate to severe atopic dermatitis (eczema) that hasn't responded well to other treatments. It aims to find a new option for controlling this chronic skin condition.
Chengdu, SichuanAges 18–75 - NCT07198555RecruitingPhase 1
Study of BBM-A101 for knee osteoarthritis
This trial tests a new medicine called BBM-A101 for people with moderate knee osteoarthritis. It aims to see if it is safe and helps reduce pain and improve function.
Shenzhen, GuangdongAges 40–75 - NCT07202546RecruitingPhase 2
New oral HIV drug trial for people new to treatment
This trial tests a new oral HIV medication (VH4524184) in people who have never taken HIV treatment before. It looks at how well the drug controls the virus and how safe it is.
Bakersfield, CaliforniaAges 18 years+ - NCT07197099Recruiting
Plasma exchange for immune-related nerve diseases
This study looks at whether removing and replacing blood plasma (called therapeutic plasma exchange or TPE) can help people with immune-related nerve or brain conditions. It includes both new and returning cases that meet standard guidelines for this treatment.
CairoAges Any age - NCT07194837Recruiting
Laser treatment for root canal retreatment healing
This trial tests whether a special laser (810 nm diode) can help heal infections around the root tip after a failed root canal. It is for people who have a single-rooted tooth that needs retreatment.
CairoAges 20–45 - NCT07200453Recruiting
E-learning program to improve digital health skills for cancer patients
This trial tests an interactive e-learning tool designed to help cancer patients better understand and use digital health information. It aims to boost your digital health literacy, making it easier to navigate online resources and manage your care.
Hamburg, Free and Hanseatic City of HamburgAges 18 years+ - NCT07197216Enrolling by invitation
Tap trust program for water security and drinking
This trial tests a program called Tap Trust to see if it can help families in certain childcare centers feel more secure about their water and drink more water. If you are a parent or caregiver of a preschooler from a specific study group, this might be for you.
Stanford, CaliforniaAges 18 years+ - NCT07197515Recruiting
Legal help for people with advanced cancer
This study looks at whether offering legal help can improve cancer care for people with advanced cancer. Participants will get a legal screening and possibly referrals to address problems like insurance or housing.
Birmingham, AlabamaAges 18 years+ - NCT07194161Recruiting
Study on quality of life after pilonidal cyst recurrence
This study looks at how a return of a pilonidal cyst (an infected bump near the tailbone) affects your quality of life. It is for people who had a first treatment with either surgery or laser and now have a recurrence at least 6 months later.
LyonAges 14 years+ - NCT07195123Recruiting
Testing the SMART IBD app for kids with IBD
This study tests whether a smartphone app called SMART IBD can help children with IBD take their medications more consistently. It is for children who are currently missing more than 1 in 7 doses of their daily or weekly IBD medication.
Cincinnati, OhioAges 13–17 - NCT07193862RecruitingEarly Phase 1
Testing a tiny device to find best treatments for liver tumors
This study tests a tiny device that is placed in your liver tumor during surgery. It checks how well different chemotherapy drugs work on your specific cancer, which may help your doctor choose the best treatment for you.
Lake Success, New YorkAges 18 years+ - NCT07195890Enrolling by invitation
Teen Mental Health First Aid for Hong Kong students
This trial tests whether a Teen Mental Health First Aid course helps students in Hong Kong secondary schools better support peers with mental health struggles. It is for students in Forms 4–6 whose schools are already offering the course.
Hong Kong, HksarAges 14–18
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.